HARBIN GLORIA PHARMACEUTICALS Co., LTD Company Description

HARBIN GLORIA PHARMACEUTICALS Co., LTD, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally.

The company offers cardiovascular and cerebrovascular drugs, musculoskeletal drugs, vitamin supplements, electrolyte drugs, hypoglycemic drugs, analgesics, digestive system and metabolic drugs, anti-infective drugs, and anti-tumor drugs.

It also provides deer antler polypeptide injections, Annao pills and tablets, potassium chloride sustained-release tablets, sodium creatine phosphate for injection, ginkgo biloba extract injections, vitamins (B12), fluorouracil for injection, bleomycin hydrochloride for injection, and other injectable products, as well as pravastatin sodium tablets, olmesartan medoxomil amlodipine tablets, and edoxaban tosylate tablets.

In addition, the company engages in pharmaceutical promotion; project investment; investment services; trade import and export; wholesale and retail; and technology promotion and application services.

Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is headquartered in Harbin, the People’s Republic of China.

HARBIN GLORIA PHARMACEUTICALS Co., LTD

Country	China
Founded	2000
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	2,350
CEO	Leifeng Guo

Contact Details

Address: No. 29, Beijing Road Harbin, 150025 China
Phone	86 451 5735 1368
Website	gloria.cc

Stock Details

Ticker Symbol	002437
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100000QG8
SIC Code	2834

Key Executives

Name	Position
Leifeng Guo	GM, Chief Financial Officer and Director
Kang Zhou	Deputy GM and Non-Independent Director
Yueyin Liu	Deputy GM, Non-Independent Director and Secretary of the Board
Xiaohang Wang	Deputy General Manager
Runbao Li	Deputy General Manager
Xiaojing Zhou	Accounting Supervisor